| abstract |
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for treating, delaying, slowing the progression of, and/or preventing renal injury or fatty liver injury. An angiotensin converting enzyme (ACE) inhibitor selected from the group consisting of (a) canagliflozin and (b) benazepril, captopril, enalapril, imidapril, lisinopril and ramipril, or candesartan, irbesartan, losartan and valsartan. An angiotensin receptor blocker (ARB) selected from the group and a pharmaceutically acceptable carrier, which reduces the urinary albumin/creatinine ratio in the subject by about 30% or more after being administered to the subject, Pharmaceutical composition. [Selection diagram] None |